The brain is highly enriched in lipids, which make up approximately 60% of its dry weight (1, 2). Among them, PUFAs are important constituents of brain membrane phospholipids. The main PUFAs in the brain are n-6 arachidonic acid (ARA; 20:4n-6) and n-3 DHA (22:6n-3), which represent approximately 9% and 15% of total fatty acids, respectively (3, 4). Other less abundant PUFAs in the brain include n-6 linoleic acid (LNA; 18:2n-6), dihomo--linolenic acid (20:3n-6), n-3 -linolenic acid (ALA; 18:3n-3), and EPA (20:5n-3) (5). Irrespective of their abundance, these PUFAs, along with ARA and DHA, regulate several signaling processes within the brain (6-9). PUFAs are precursors to oxidized metabolites, also known as oxylipins (10), that are synthesized by cyclooxygenase (COX) (11, 12), lipoxygenase (LOX) (13, 14), cytochrome P450 (CYP) (15-17), 15-hydroxyprostaglandin dehydrogenase (PGDH) (18, 19), and soluble epoxide hydrolase (sEH) enzymes (20, 21). In the brain, these enzymes synthesize hundreds of oxylipins from a limited number of PUFA precursors (22-26). Oxylipins regulate multiple physiological processes within the brain, including synaptic transmission (27-29), vasodilation (30, 31), angiogenesis (32), neuronal morphology (33, 34), blood flow (30), and pro-or anti-inflammatory signaling (35-40).